Zerenex: Phase II data

Data from an open-label Phase II trial in 55 patients showed that 4 weeks of Zerenex led to a mean serum phosphorous level of about 5.4 mg/dL, down from about 5.9 mg/dL at baseline. In a subset of 29 ...